Daniel R. Passeri
CHIEF EXECUTIVE OFFICER at Cue Biopharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cue Biopharma Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cue Biopharma Inc. June 4, 202582.1%
-
Cue Biopharma Inc. June 5, 202494.5%
-
Cue Biopharma Inc. June 7, 202383.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 16, 2024 | Cue Biopharma Inc. | Open-market purchase | +30,000 | $1.03 | $30,900 |
| Aug 14, 2023 | Cue Biopharma Inc. | Open-market purchase | +3,000 | $2.86 | $8,580 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.